Get informed when a big investor buys or sells
+ FollowOctober 29, 2026 - AI Summary
Loading insider trades…
Loading congress trades…
| Market cap | $129.66 Billion |
|---|---|
| Enterprise Value | $164.89 Billion |
| Dividend yield | 3.97% |
| Earnings per Share | $5.51 |
| Beta | 1.34 |
| Outstanding Shares | 706,200,000 |
| P/E Ratio | 14.03 |
|---|---|
| PEG | -791.98 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 3.3 |
| Enterprise Value to EBIT | 16.12 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 1.91 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse p...